We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Back to rankings

2 hedge funds and large institutions have $215K invested in Acura Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

42% less capital invested

Capital invested by funds: $372K → $215K (-$157K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ACUR Hedge Fund Activity: Q4 2018 in Review

2 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q4 2018, worth a combined $215K — down 42% from $372K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ACUR positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Acura Pharmaceuticals (ACUR) as of Q4 2018, up from 1 in Q3 2018.
  • Funds reported $215K of Acura Pharmaceuticals stock for Q4 2018, down 42% quarter-over-quarter.
  • 1 fund opened new Acura Pharmaceuticals positions in Q4 2018 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2018.